GLS and central nervous system cancer: Figure 1A showed that CDKN2A, FDX1, DLD, DLAT, LIAS, LIPT1, MTF1, PDHA1, and PDHB were highly expressed in the tumors of TCGA glioma patients than in normal tissues, and the GLS expression was significantly reduced.